0001179110-15-012160.txt : 20150814 0001179110-15-012160.hdr.sgml : 20150814 20150814163813 ACCESSION NUMBER: 0001179110-15-012160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150812 FILED AS OF DATE: 20150814 DATE AS OF CHANGE: 20150814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUTTER MARTIN P CENTRAL INDEX KEY: 0001017832 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 151056515 MAIL ADDRESS: STREET 1: 2170 BUCKTHORNE PLACE STREET 2: SUITE 170 CITY: THE WOODLAND STATE: TX ZIP: 77380 4 1 edgar.xml FORM 4 - X0306 4 2015-08-12 0 0000815094 ABIOMED INC ABMD 0001017832 SUTTER MARTIN P 22 CHERRY HILL DRIVE DANVERS MA 01923 1 0 0 0 Common Stock, $0.01 par value 2015-08-12 4 A 0 3900 0 A 162017 D Common Stock, $.01 par value 946818 I By Essex Woodland Health Ventures, VI, LP Common Stock, $0.01 par value 1203182 I By Essex Woodlands Health Ventures Fund VII, LP Stock option (right to buy) 13.91 2009-05-20 2018-05-20 Common Stock 25000 25000 D Stock Option (right to buy) 18.63 2009-08-12 2018-08-13 Common Stock 12000 12000 D Stock Option (right to buy) 7.67 2010-08-11 2019-08-12 Common Stock 12000 12000 D Stock Option (right to buy) 9.99 2011-08-10 2020-08-11 Common Stock 12000 12000 D These securities are held by Essex Woodlands Health Ventures Fund VI, L.P. Mr. Sutter is a managing director of Essex Woodlands Health Ventures, the partnership that owns the reported securities. As a managing director Mr. Sutter shares voting and investment powers for Essex Woodlands Health Ventures Fund VI, L.P.. Mr. Sutter disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein. These securities are held by Essex Woodlands Health Ventures Fund VII, L.P.. Mr. Sutter is a managing director of Essex Woodlands Health Ventures, the partnership that owns the reported securities. As a managing director Mr. Sutter shares voting and investment powers for Essex Woodlands Health Ventures Fund VII, L.P. Mr. Sutter disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein. Grant to reporting person to buy shares of Common Stock under ABIOMED, Inc. 2000 Stock Incentive Plan. These options become exerciseable in annual 20% increments commencing on the date shown forth in Table II, Column 6. Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan. Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 12, 2016; or (b) the date of the Issuer's next annual meeting of stockholders. /s/ Stephen C. McEvoy (by power of attorney) 2015-08-14 EX-24 2 ex24sutter.txt LIMITED POWER OF ATTORNEY The undersigned does hereby appoint each of Stephen McEvoy, Robert Bowen, Ian McLeod and Loretta Wedge,signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a director or officer of ABIOMED, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in- fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, this power of attorney has been executed as of the 3rd day of July, 2009 and shall remain in full force and effect until withdrawn by the undersigned in writing. Signature: /s/ Martin P. Sutter Print Name: Martin P. Sutter - 2 -